舒肝宁注射液对大鼠酒精性肝纤维化的防治作用研究
x

请在关注微信后,向客服人员索取文件

篇名: 舒肝宁注射液对大鼠酒精性肝纤维化的防治作用研究
TITLE:
摘要: 目的:考察舒肝宁注射液对酒精性肝纤维化(ALF)模型大鼠的防治作用,为其临床用于酒精性肝病的治疗提供实验参考。方法:取50只大鼠,每天ig 60%乙醇-玉米油-吡唑混悬液复制ALF模型;另取同批大鼠10只,ig生理盐水,作为正常对照组。连续16周后,将存活的造模大鼠(n=40)随机分为模型组、阳性对照组(安络化纤丸0.75 g/kg ,ig)和舒肝宁注射液高、中、低剂量组(4.8、2.4、1.2 mL/kg,ip),每组8只。正常对照组和模型组大鼠ip等体积生理盐水(5 mL/kg),给药组大鼠给予相应药物 ,每天1次,连续给药8周,并同时继续进行造模处理。给药结束后,称定大鼠体质量,检测大鼠血清中肝功能指标[天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)]和肝纤维化指标[透明质酸(HA)、层黏连蛋白(LN)、Ⅲ型前胶原(PⅢNP)和Ⅳ型胶原(Ⅳ-C)]水平,测定大鼠肝指数并观察肝组织病理变化。结果:与正常对照组比较,模型组大鼠体质量显著降低(P<0.05);肝指数以及血清中肝功能指标和肝纤维化指标水平均显著升高(P<0.05或P<0.01);肝组织出现脂肪变性、肝细胞空泡化、汇管区周围有大量纤维组织沉积等病理改变。与模型组比较,各给药组大鼠上述变化均显著改善(P<0.05或P<0.01)。结论:舒肝宁注射液可明显改善ALF模型大鼠的肝组织损伤,对酒精性肝病有一定的防治作用。
ABSTRACT: OBJECTIVE: To investigate the preventive and therapeutic effect of Shuganning injection on alcoholic liver fibrosis (ALF) in model rats, and provide experimental basis for its clinical application for alcoholic liver disease. METHODS: 50 rats were enrolled and intraperitoneally given mixed liquid of 60% alcohol-corn oil-pyrazole to reduce ALF model. Another 10 rats were enrolled and intraperitoneally given normal saline, as normal control group. After 16 weeks, survived model rats (n=40) were randomly divided into model group, positive control group (Anluo huaxian pill 0.75 g/kg, ig), Shuganning injection high-dose, medium-dose, low-dose groups (4.8, 2.4, 1.2 mL/kg, ip), 8 in each group. Normal control group and model group were intraperitoneally injected equal volume of normal saline (5 mL/kg), administration groups were given relevant medicines, once a day, for 8 weeks; and modeling was contiuously conducted at the same time. After administration, body mass of rats was weighed, and the levels of liver function indexes [aspartate aminotransferase (AST), alanine aminotransferase (ALT)] and liver fibrosis indexes [hyaluronic acid (HA), laminin (LN), type Ⅲ procollagen (PⅢNP), type Ⅳ collagen (Ⅳ-C)] in serum of rats were detected. Liver index of rats was determined and pathological changes of liver tissue were observed. RESULTS: Compared with normal control group, body mass of rats in model group was significantly decreased (P<0.05); liver index, and liver function index, liver fibrosis index levels in serum were significantly increased (P<0.05 or P<0.01). Liver tissue showed steatosis, hepatocyte vacuolization, a large number of fibrous tissue deposition around portal areas and other pathological changes. Compared with model group, above-mentioned changes were improved significantly in administration groups (P<0.05 or P<0.01). CONCLUSIONS: Shuganning injection can obviously improve liver tissue damage of model rats with ALF, showing certain preventive and therapeutic effect on alcoholic liver disease.
期刊: 2017年第28卷第19期
作者: 潘婷,张金娟,熊英,李玲,雷珊,兰金芝
AUTHORS: PAN Ting,ZHANG Jinjuan,XIONG Ying,LI Ling,LEI Shan,LAN Jinzhi
关键字: 舒肝宁注射液;酒精性肝纤维化;大鼠
KEYWORDS: Shuganning injection; Alcoholic liver fibrosis; Rats
阅读数: 433 次
本月下载数: 3 次

* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!